These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14623002)

  • 21. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Okamoto K; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin.
    Renau TE; Léger R; Flamme EM; Sangalang J; She MW; Yen R; Gannon CL; Griffith D; Chamberland S; Lomovskaya O; Hecker SJ; Lee VJ; Ohta T; Nakayama K
    J Med Chem; 1999 Dec; 42(24):4928-31. PubMed ID: 10585202
    [No Abstract]   [Full Text] [Related]  

  • 23. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract]   [Full Text] [Related]  

  • 24. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
    Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
    J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorinated phenols control the expression of the multidrug resistance efflux pump MexAB-OprM in Pseudomonas aeruginosa by interacting with NalC.
    Ghosh S; Cremers CM; Jakob U; Love NG
    Mol Microbiol; 2011 Mar; 79(6):1547-56. PubMed ID: 21231970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model.
    Nakayama K; Kawato H; Watanabe J; Ohtsuka M; Yoshida K; Yokomizo Y; Sakamoto A; Kuru N; Ohta T; Hoshino K; Yoshida K; Ishida H; Cho A; Palme MH; Zhang JZ; Lee VJ; Watkins WJ
    Bioorg Med Chem Lett; 2004 Jan; 14(2):475-9. PubMed ID: 14698185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa.
    Li XZ; Zhang L; Poole K
    J Antimicrob Chemother; 2000 Apr; 45(4):433-6. PubMed ID: 10747818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa.
    Li XZ; Poole K
    J Bacteriol; 2001 Jan; 183(1):12-27. PubMed ID: 11114896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India.
    Choudhury D; Ghose A; Dhar Chanda D; Das Talukdar A; Dutta Choudhury M; Paul D; Maurya AP; Chakravarty A; Bhattacharjee A
    PLoS One; 2016; 11(2):e0149156. PubMed ID: 26866484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump.
    Morita Y; Komori Y; Mima T; Kuroda T; Mizushima T; Tsuchiya T
    FEMS Microbiol Lett; 2001 Aug; 202(1):139-43. PubMed ID: 11506922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The substrate specificity of tripartite efflux systems of Pseudomonas aeruginosa is determined by the RND component.
    Murata T; Kuwagaki M; Shin T; Gotoh N; Nishino T
    Biochem Biophys Res Commun; 2002 Nov; 299(2):247-51. PubMed ID: 12437977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719.
    Cao L; Srikumar R; Poole K
    Mol Microbiol; 2004 Sep; 53(5):1423-36. PubMed ID: 15387820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.
    Buyck JM; Guénard S; Plésiat P; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2012 Mar; 67(3):771-5. PubMed ID: 22218683
    [No Abstract]   [Full Text] [Related]  

  • 38. Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa.
    Renau TE; Léger R; Yen R; She MW; Flamme EM; Sangalang J; Gannon CL; Chamberland S; Lomovskaya O; Lee VJ
    Bioorg Med Chem Lett; 2002 Mar; 12(5):763-6. PubMed ID: 11858997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position.
    Yoshida K; Nakayama K; Kuru N; Kobayashi S; Ohtsuka M; Takemura M; Hoshino K; Kanda H; Zhang JZ; Lee VJ; Watkins WJ
    Bioorg Med Chem; 2006 Mar; 14(6):1993-2004. PubMed ID: 16290941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.